Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Marcel Legault Insider Profile
4 Followers
Daniel Marcel Legault, Chief Executive Officer at Antibe Therapeutics, holds 671.67K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Daniel Marcel Legault Bought $75,000 shares of Antibe Therapeutics on Sep 25, 2020 for an estimated value of 25.50K.
Daniel Marcel Legault Antibe Therapeutics (ATBPF)Chief Executive Officer
Antibe Therapeutics (ATBPF)
Chief Executive Officer
Ranked #1,943 out of 78,624 Corporate Insiders
Profitable Transactions
9 out of 9 Profitable Transactions
Average Return
+48.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel Marcel Legault's holdings
Insider Roles
Chief Executive Officer
Roles that Daniel Marcel Legault holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 28, 2019 - Feb 28, 2020
Return:+116.20%
The most profitable trade made by Daniel Marcel Legault
Daniel Marcel Legault's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Marcel Legault's performance on stock
You May Also Like
Daniel Marcel Legault insider profile FAQ
What is the percentage of profitable transactions made by Daniel Marcel Legault?
The percentage of profitable transactions made by Daniel Marcel Legault is 100%.
What is the average return per transaction made by Daniel Marcel Legault?
The average return per transaction made by Daniel Marcel Legault is 48.80%.
What stocks does Daniel Marcel Legault hold?
Daniel Marcel Legault holds: ATBPF stocks.
What was Daniel Marcel Legault’s latest transaction?
Daniel Marcel Legault latest transaction was an Informative Buy of $25.50K.
What was Daniel Marcel Legault's most profitable transaction?
Daniel Marcel Legault’s most profitable transaction was an Informative Buy of ATBPF stock on February 28, 2019. The return on the trade was 116.20%.
What is Daniel Marcel Legault's role in Antibe Therapeutics?
Daniel Marcel Legault's role in Antibe Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.